Logo image of AERT

AERIES TECHNOLOGY INC (AERT) Stock Fundamental Analysis

NASDAQ:AERT - Nasdaq - KYG0136H1020 - Common Stock - Currency: USD

0.8501  -0.01 (-1.45%)

Fundamental Rating

0

Taking everything into account, AERT scores 0 out of 10 in our fundamental rating. AERT was compared to 82 industry peers in the Professional Services industry. AERT may be in some trouble as it scores bad on both profitability and health. AERT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AERT has reported negative net income.
In the past year AERT has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: AERT reported negative net income in multiple years.
AERT had negative operating cash flow in 4 of the past 5 years.
AERT Yearly Net Income VS EBIT VS OCF VS FCFAERT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 10M -10M -20M

1.2 Ratios

AERT has a worse Return On Assets (-49.49%) than 92.68% of its industry peers.
Industry RankSector Rank
ROA -49.49%
ROE N/A
ROIC N/A
ROA(3y)-4.55%
ROA(5y)-3.48%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AERT Yearly ROA, ROE, ROICAERT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100 -100 200 300

1.3 Margins

The Gross Margin of AERT (23.82%) is worse than 70.73% of its industry peers.
AERT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AERT Yearly Profit, Operating, Gross MarginsAERT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

0

2. Health

2.1 Basic Checks

AERT does not have a ROIC to compare to the WACC, probably because it is not profitable.
AERT has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, AERT has a worse debt to assets ratio.
AERT Yearly Shares OutstandingAERT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 10M 20M 30M 40M
AERT Yearly Total Debt VS Total AssetsAERT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -1.52, we must say that AERT is in the distress zone and has some risk of bankruptcy.
AERT's Altman-Z score of -1.52 is on the low side compared to the rest of the industry. AERT is outperformed by 87.80% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.52
ROIC/WACCN/A
WACC9.06%
AERT Yearly LT Debt VS Equity VS FCFAERT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.66 indicates that AERT may have some problems paying its short term obligations.
With a Current ratio value of 0.66, AERT is not doing good in the industry: 90.24% of the companies in the same industry are doing better.
AERT has a Quick Ratio of 0.66. This is a bad value and indicates that AERT is not financially healthy enough and could expect problems in meeting its short term obligations.
AERT's Quick ratio of 0.66 is on the low side compared to the rest of the industry. AERT is outperformed by 89.02% of its industry peers.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66
AERT Yearly Current Assets VS Current LiabilitesAERT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for AERT have decreased strongly by -156.01% in the last year.
Looking at the last year, AERT shows a decrease in Revenue. The Revenue has decreased by -3.19% in the last year.
EPS 1Y (TTM)-156.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-106.71%
Revenue 1Y (TTM)-3.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.31%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AERT Yearly Revenue VS EstimatesAERT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 20M 40M 60M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AERT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AERT Price Earnings VS Forward Price EarningsAERT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AERT Per share dataAERT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AERT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AERIES TECHNOLOGY INC

NASDAQ:AERT (8/6/2025, 4:00:41 PM)

0.8501

-0.01 (-1.45%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)09-26 2025-09-26
Inst Owners2.48%
Inst Owner ChangeN/A
Ins Owners69.37%
Ins Owner Change-0.05%
Market Cap40.08M
AnalystsN/A
Price TargetN/A
Short Float %0.49%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.57
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS1.49
BVpS-0.12
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -49.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.82%
FCFM N/A
ROA(3y)-4.55%
ROA(5y)-3.48%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.76
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 107.23%
Cap/Sales 2.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z -1.52
F-Score3
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)118.72%
Cap/Depr(5y)124.02%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-156.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-106.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.19%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1063.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.53%
OCF growth 3YN/A
OCF growth 5YN/A